Please login to the form below

Not currently logged in
Email:
Password:

neuroscience

This page shows the latest neuroscience news and features for those working in and with pharma, biotech and healthcare.

Lilly partners with AC Immune on tau drug for Alzheimer’s

Lilly partners with AC Immune on tau drug for Alzheimer’s

Other companies working on tau include Eisai/Biogen who are looking at combining a tau blocker with an anti-amyloid drug, as well as Bristol-Myers Squibb, Axon Neuroscience and Astellas.

Latest news

More from news
Approximately 9 fully matching, plus 151 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    She made major scientific contributions to neuroscience R&D within the pharmaceutical industry at GlaxoSmithkline, and also championed the vision for the Stevenage Bioscience Catalyst and theEuropean Innovative Medicines Initiative (IMI).

  • Pfizer and IBM's tech-enabled 'Parkinson’s house' Pfizer and IBM's tech-enabled 'Parkinson’s house'

    David Gray, senior neuroscientist at Pfizer’s Neuroscience Research Centre, adds: “One of the reasons we started BlueSky is that we wanted to show that what we are bringing forward is ... Since this article was written Pfizer has substantially scaled

  • Perfecting the pharmaceutical pipeline with AI Perfecting the pharmaceutical pipeline with AI

    with the Sheffield Institute of Translational Neuroscience at Sheffield University, a world authority on ALS, we are now testing some of these hypotheses in the lab.

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    It also recently launched neuroscience company Cerevance in Cambridge, Massachusetts in partnership with Lightstone Ventures, with the 25-person research team coming from Takeda’s Cambridge UK site.

  • Deal Watch August 2016 Deal Watch August 2016

    It has the same therapy areas as AstraZeneca apart from respiratory but also has neuroscience/pain, rare disease, vaccines and biosimilars.

More from intelligence
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics